Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinggan Sanjie Xiaoying Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Sun Simiao Hospital of Beijing University of Traditional Chinese Medicine. It is primarily investigated for the treatment of Hashimoto's thyroiditis, an autoimmune condition characterized by chronic inflammation of the thyroid gland. The decoction (or its granule form) is designed based on TCM principles to clear the liver, dissipate nodules, and reduce swelling. Clinical evaluation, such as trial ChiCTR2200063293, focuses on its efficacy in managing thyroid function and reducing thyroid autoantibody levels in patients with Hashimoto's thyroiditis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qinggan Sanjie Xiaoying Decoction.